Not applicableUnknownNCT03016455What this trial is testingB Cell Lymphocyte in Humoral Rejection and AlloimmunisationWho this might be right forRenal Transplant University Hospital, Brest 125
Not applicableStudy completedNCT01616329What this trial is testingR-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell TransfusionsWho this might be right forHemolysis Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 1,500
Large-scale testing (Phase 3)Study completedNCT00005782What this trial is testingMobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell TraitWho this might be right forSickle Cell Trait National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Not applicableStudy completedNCT03405402What this trial is testingTransfusion in Sickle Cell Disease: Risk Factors for AlloimmunizationWho this might be right forSickle Cell Disease Hanane EL KENZ 173
Testing effectiveness (Phase 2)Ended earlyNCT06435845What this trial is testingPhase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a AlloimmunizationWho this might be right forFetal and Neonatal Alloimmune Thrombocytopenia Rallybio 1
Large-scale testing (Phase 3)Study completedNCT00295516What this trial is testingDoppler or Amniocentesis to Predict Fetal AnemiaWho this might be right forRh Isoimmunization University of Toronto 157
Not applicableStudy completedNCT05345561What this trial is testingStudy to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune ThrombocytopeniaWho this might be right forFetal and Neonatal Alloimmune Thrombocytopenia Rallybio 14,390
Large-scale testing (Phase 3)Study completedNCT00000589What this trial is testingTrial to Reduce Alloimmunization to Platelets (TRAP)Who this might be right forBlood PlateletsHematologic DiseasesImmunization+2 more National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)UnknownNCT03104426What this trial is testingEPO-4-Rhesus StudyWho this might be right forErythroblastosis, FetalErythroblastosis Fetalis, Rh DiseaseErythroblastosis Fetalis Due to RH Antibodies+1 more Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 42
Testing effectiveness (Phase 2)Study completedNCT03842189What this trial is testingEvaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)Who this might be right forHemolytic Disease of the Fetus and Newborn Janssen Research & Development, LLC 25
Not applicableLooking for participantsNCT07414511What this trial is testingHemophilia A Research ProgramWho this might be right forHemophilia AHemophilia A, SevereFactor VIII (FVIII)+10 more University of Washington 500
Not applicableActive Not RecruitingNCT06231719What this trial is testingEfficacy of Manuel Pressure and Local Cold Spray in Reducing Injection Pain in Pregnant WomenWho this might be right forPain, AcuteAlloimmunisation in PregnancyInjection Site+1 more Gulsum Coskun 129
Not applicableStudy completedNCT00199628What this trial is testingResearch Network for Neonatal Diseases Induced by Tissular Fetomaternal AlloimmunizationWho this might be right forGlomerulonephritis, MembranousNeonatal Diseases and AbnormalitiesHemochromatosis University Hospital, Limoges 100
Not applicableStudy completedNCT02858323What this trial is testingComplement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet TransfusionWho this might be right forThrombocytopeniaPlatelet Transfusion Refractoriness National Institutes of Health Clinical Center (CC) 68
Not applicableStudy completedNCT00456118What this trial is testingStudy of the Role of Tissular Maternofetal Alloimmunization in Placentation PathologiesWho this might be right forRecurrent Pregnancy LossesPreeclampsiaIntervillositis University Hospital, Limoges 83
Not applicableUnknownNCT03288012What this trial is testingSickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and GeneticsWho this might be right forAlloimmunizationSickle Cell Disease Sanquin Research & Blood Bank Divisions 150
Not applicableNot Yet RecruitingNCT06113224What this trial is testingCharacterization of Anti-HLA Alloimmunization After Pulmonary Valve Homograft InsertionWho this might be right forLung Graft Dysfunction Assistance Publique Hopitaux De Marseille 53
Not applicableStudy completedNCT01282021What this trial is testingMolecular Immunohematology in Ethiopian Sub-PopulationsWho this might be right forImmunohematology National Institutes of Health Clinical Center (CC) 95
Not applicableNot Yet RecruitingNCT05890430What this trial is testingStudy of Alloimmune Response in Humoral Rejection After Kidney TransplantationWho this might be right forKidney TransplantationKidney Allograft BiopsyHumoral Rejection+1 more University Hospital, Strasbourg, France 570
Not applicableLooking for participantsNCT06944067What this trial is testingStudy to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell DiseaseWho this might be right forSickle Cell Disease National Human Genome Research Institute (NHGRI) 50